Clinical Research Site

Albany, New York 12209

0 studies enrolling now · 3 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Focal Segmental Glomerulosclerosis, Membranous Nephropathy, Minimal Change Disease

Studies at this site

• Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy — Stopped early
• Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) — Stopped early
• Study in Subjects Greater Than 40 Years of Age With COPD — Completed